Operator Welcome to the Match Group fourth quarter 2024 earnings conference call. [Operator instructions] Please note, this ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.CTQLEHs_.js ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.CTQLEHs_.js ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Q4 2024 Management View CEO Gordon Hardie highlighted that 2024 was challenging due to sluggish demand and macroeconomic headwinds. The company reported a full-year adjusted EPS of $0.81, which ...

Revenue of $146.8 million (ZAR 2.6 billion) was at the upper end of our Revenue guidance and compares to $143.9 million (ZAR ...

First quarter revenue was $90.8 million in fiscal 2025 versus $97.9 million in fiscal 2024, primarily reflecting small ...